Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when the clinical lead proposal form relating to abiraterone acetate as a treatment for advanced high risk non-metastatic prostate cancer was (a) completed and (b) sent to the Clinical Effectiveness Team (NHS England) under section A1.4 of Methods: National clinical policies.

The application form for a clinical policy relating to this treatment was initially received by NHS England on 29 March 2022. The policy proposition continues to be developed in line with NHS England’s document, Methods: national clinical policies.